NICOTINAMIDE ADENINE DINUCLEOTIDE 1000MG & RETATRUTIDE : A UK REPORT

The emerging interest in NAD+ supplementation, particularly at a substantial dosage of 1000mg , continues to rise within the British medical community. At the same time , attention is firmly fixed on Retatrutide, a novel GLP-1 analogue being viewed by many as a potential successor to Tirzepatide.